Is it cheaper to pay cash for GLP-1s than use my insurance?
This article is for general education only. It is not medical advice, and it is not a substitute for a consultation with a licensed physician. Treatment decisions, including whether any medication is appropriate for you, are made by a licensed physician after reviewing your health history.
Often, yes. If your plan excludes weight loss GLP-1s or you have an unmet high deductible, 2026 cash prices of $149 to $499 per month through manufacturer programs typically cost less. If you have a genuine copay, insurance usually wins.
The cash math changed dramatically once manufacturers opened direct channels. NovoCare Pharmacy sells Wegovy pens for $349 to $399 per month (with a $199 introductory price on starter doses through December 31, 2026) and Wegovy pills for $149 to $199 per month. LillyDirect sells Zepbound vials and pens for $299 to $449 per month. The government's TrumpRx platform lists injectable GLP-1s at an average of $350 per month, with oral starting doses at $150. These prices cover the medication only; the prescription visit, labs, and any program fees are separate.
Whether insurance beats those numbers depends on three things: whether your plan covers GLP-1s for weight loss at all (in 2025, only 43% of the largest employers did, and coverage drops sharply at smaller firms), whether you have met your deductible, and how large your copay is. A covered prescription with a $25 to $50 copay beats every cash price. A denied prior authorization, an excluded benefit, or a January fill on a high-deductible plan usually does not.
The practical move is to price both routes before you fill. Ask the pharmacy what your plan would charge today, get the manufacturer's cash quote, and compare total annual cost rather than a single month. A provider cost calculator can help you line up the full picture across visit fees, medication, and labs.
How much do GLP-1s cost if you pay cash in 2026?
Branded GLP-1s now cost $149 to $499 per month cash, depending on the drug, dose, and channel. NovoCare Pharmacy prices Wegovy pens at $349 per month for standard doses and $399 for the 7.2 mg high dose, with starter-dose pens at an introductory $199 through December 31, 2026. Wegovy pills run $149 to $199 per month. LillyDirect prices Zepbound at $299 for 2.5 mg, $399 for 5 mg, and $449 for 7.5 mg through 15 mg, provided refills happen within a 45 day window; miss the window and the discounted price is forfeited. TrumpRx lists injectable GLP-1s at an average of $350 per month.
These prices are medication only. They exclude the prescribing visit, lab work, and shipping in some cases. Telehealth services bundle this differently; Sipra, for example, charges a $99/mo membership covering unlimited physician visits, with GLP-1 medication from $79/mo priced by plan length rather than dose, from $178/mo all in. Full cost is disclosed before checkout.
When does using insurance cost more than paying cash?
Insurance costs more than cash in three common situations: your plan excludes weight loss GLP-1s, your deductible is unmet, or your prior authorization is denied. Exclusion is the most common. Per the KFF 2025 Employer Health Benefits Survey, 43% of firms with 5,000 or more workers covered GLP-1s for weight loss, but only 30% of firms with 1,000 to 4,999 workers and 16% of firms with 200 to 999 workers did. If your plan excludes the drug, insurance offers you nothing to compare; cash is the only route.
High-deductible plans create the second trap. Until you meet the deductible, you pay the plan's negotiated price, which for branded GLP-1 injectables typically runs well above the manufacturer cash channels. Early in the plan year, cash frequently wins even on covered plans.
When is insurance clearly the better deal?
Insurance wins whenever you have real coverage with a modest copay. If your plan covers the prescription and your copay lands at $25 to $100 per month, no cash channel comes close. Commercially insured patients with coverage can also use the Wegovy savings offer to pay as little as $25 per month, with maximum savings of $100 per month, subject to eligibility.
Medicare enrollees got a new option in July 2026: the Medicare GLP-1 Bridge program offers Wegovy, all formulations of Foundayo, and the Zepbound KwikPen at a flat $50 monthly copayment through December 31, 2027, for beneficiaries in participating Part D plans. For those who meet a program's eligibility rules, these options usually beat every cash price; check them before defaulting to cash.
What about compounded GLP-1s as a cash-pay option?
Compounded semaglutide and tirzepatide exist only as cash-pay options, since insurance does not cover them, and they are often priced below branded cash channels. As of 2026, after the FDA shortage resolutions, compounded versions are available only where a licensed physician determines a patient-specific clinical need. The physician decides whether branded or compounded is appropriate for you; it is not available in every case or state.
Availability varies by state. Telehealth prescribing rules, pharmacy options, and specific medications differ depending on where you live, so the cash options you can actually access depend on your location and your physician's judgment.
Does paying cash count toward my deductible or out-of-pocket maximum?
No. Cash purchases made outside your insurance plan do not count toward your deductible or out-of-pocket maximum, and that is the real cost of choosing cash. If you expect major medical expenses later in the year, running the GLP-1 through insurance at a higher monthly price can still pay off by exhausting your deductible sooner.
Note that even the Medicare GLP-1 Bridge copayment works this way: per KFF, the $50 monthly payment does not count toward the Part D deductible or the annual out-of-pocket maximum. Factor the whole year into the decision, not just this month's fill.
How do I figure out which is cheaper for me?
Price both routes before you fill anything. First, ask your pharmacy or plan what the prescription costs through insurance today, at your current deductible status. Second, get the cash quote from NovoCare Pharmacy, LillyDirect, or TrumpRx for your specific drug and dose. Third, compare annual totals, not single months: account for introductory prices that expire, dose changes that move you into higher price tiers, and whether insurance payments would help you meet a deductible you will hit anyway.
Include the costs around the medication too, since visit fees and labs differ by provider. Sipra's provider cost calculator at /calculators/provider-cost lets you compare the all-in monthly cost across providers side by side.
Cash vs insurance: what a month of GLP-1s costs in 2026
| Option | Monthly cost | Key condition |
|---|---|---|
| Insurance copay (covered plan) | $25 to $100+ | Plan must cover weight loss GLP-1s; prior authorization usually required |
| Wegovy savings offer (with commercial coverage) | As little as $25 | Max savings $100/month; eligibility rules apply |
| Medicare GLP-1 Bridge | $50 copay | July 2026 to Dec 2027; participating Part D plans; select products |
| NovoCare Pharmacy, Wegovy pens (cash) | $349 to $399 ($199 intro on starter doses) | Intro price runs through Dec 31, 2026 |
| NovoCare Pharmacy, Wegovy pills (cash) | $149 to $199 | $149 offer on 4 mg ends Aug 31, 2026 |
| LillyDirect, Zepbound vials/pens (cash) | $299 to $449 | $449 top-dose price requires refill within 45 days |
| TrumpRx platform (cash) | About $350 average (injectables) | Oral starting doses listed at $150 |
| Covered plan, deductible unmet | Typically well above cash prices | Negotiated price applies until deductible is met |
Prices as of July 2026 and medication only; visits, labs, and fees are separate. Manufacturer offers change and some introductory prices expire during 2026.
Bottom line
If your insurance covers weight loss GLP-1s and your copay is under about $150, use insurance. If your plan excludes them, your prior authorization was denied, or you are staring at an unmet high deductible, cash channels at $149 to $499 per month are usually the cheaper route in 2026.
Price both before you fill: get your plan's number from the pharmacy, get the manufacturer's cash quote, and compare the full year, not one month.
Compare provider costsMore questions, answered
Can I use my HSA or FSA to pay cash for GLP-1s?
Generally yes. Prescription medications are qualified medical expenses, so HSA or FSA dollars can typically cover cash-pay GLP-1 purchases from manufacturer pharmacies, which effectively discounts the price by your tax rate. Confirm with your plan administrator, and keep the prescription and receipts. The purchase still does not count toward your insurance deductible.
Do manufacturer savings cards work if I have no insurance?
The lowest offers do not. The $25 Wegovy savings offer requires commercial insurance that covers the drug. Without coverage, you use the self-pay prices instead: $149 to $399 through NovoCare Pharmacy for Wegovy and $299 to $449 through LillyDirect for Zepbound. Government beneficiaries such as Medicare and Medicaid enrollees are excluded from commercial savings cards.
Related questions
Lose weight with a plan made just for you
- Same-day doctor visits and prescriptions
- Semaglutide, tirzepatide & other GLP-1s
- FSA & HSA eligible with all plans
*Price includes medication only. Active $99/mo Sipra membership required.
Was this helpful?